August 10, 2011
'Serial Killer' T-Cells Put Cancer in Remission
Sarah Williams, Science Now
The patient was dying of leukemia. One hundred seventy out of every 200 cells in his bone marrow had a cancer-causing mutation, and his lymph nodes were swelling, a sign the cancer was getting worse. He'd already been on multiple courses of chemotherapy, but his disease showed few signs of improvement. Then, in July 2010, he enrolled in a clinical trial for an experimental treatment, designed to turn his own immune cells against his cancer. Months later, all signs of leukemia had vanished, his physicians report today.
TAGGED: Gene Therapy, Cancer Treatment, Cancer, T-cells, Experimental Drug